Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 1
1988 1
1989 2
1990 5
1991 8
1992 10
1993 18
1994 18
1995 20
1996 45
1997 68
1998 66
1999 68
2000 65
2001 62
2002 81
2003 65
2004 72
2005 75
2006 48
2007 41
2008 55
2009 55
2010 48
2011 54
2012 52
2013 47
2014 48
2015 56
2016 51
2017 42
2018 35
2019 38
2020 35
2021 49
2022 33
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 11238495

1,410 results

Results by year

Filters applied: . Clear all
Page 1
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ; MK-677/Alendronate Study Group. Murphy MG, et al. J Clin Endocrinol Metab. 2001 Mar;86(3):1116-25. doi: 10.1210/jcem.86.3.7294. J Clin Endocrinol Metab. 2001. PMID: 11238495 Clinical Trial.
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.
Body JJ, Gaich GA, Scheele WH, Kulkarni PM, Miller PD, Peretz A, Dore RK, Correa-Rotter R, Papaioannou A, Cumming DC, Hodsman AB. Body JJ, et al. J Clin Endocrinol Metab. 2002 Oct;87(10):4528-35. doi: 10.1210/jc.2002-020334. J Clin Endocrinol Metab. 2002. PMID: 12364430 Clinical Trial.
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW, Emkey R, Meunier PJ, Miller SS, Mulloy AL, Recker RR, Weiss SR, Heyden N, Musliner T, Suryawanshi S, Yates AJ, Lombardi A. Bone HG, et al. J Clin Endocrinol Metab. 2000 Feb;85(2):720-6. doi: 10.1210/jcem.85.2.6393. J Clin Endocrinol Metab. 2000. PMID: 10690882 Clinical Trial.
1,410 results